INTRODUCTION
Clostridium difficile is known to produce a number of factors that contribute to its virulence, including two related toxins: toxin A, an enterotoxin, and toxin B, a cytotoxin (Lyerly et al., 1986) . The toxin A-and Bencoding genes (tcdA and tcdB) are part of a 19.6 kb pathogenicity locus consisting of five genes including tcdC, which negatively regulates toxin synthesis (Matamouros et al., 2007) . However, in recent years, increasing numbers of pathogenic C. difficile strains have been reported with truncated versions of toxin A and/or B, and there appears to be considerable variation in the pathogenicity locus (Borriello et al., 1992; Depitre et al., 1993; Pituch et al., 2003; Toyokawa et al., 2003; van den Berg et al., 2004) . Disturbingly, the reported incidence of C. difficile-associated disease has increased significantly in the last decade, with a new group of highly virulent strains causing outbreaks of increased severity in North America and Europe (Loo et al., 2005; McDonald et al., 2005; Pépin et al., 2005; Warny et al., 2005) . The origin of these strains (called BI/NAP1/027 hypervirulent strains) is uncertain, although it has been proposed that increased use of fluoroquinolone antibiotics may give the strains a selective advantage (Pépin et al., 2005) . It has been proposed that the increased virulence could be attributed to inactivation of the negative regulator (tcdC), resulting in overexpression of tcdA and tcdB. However, an 18 bp deletion within tcdC has been identified in both hypervirulent and nonhypervirulent isolates , and is not responsible for hypertoxigenicity (Matamouros et al., 2007) . Interestingly, a 1 bp deletion at the 59 end of tcdC, which results in truncation of the protein, has been described for BI/NAP1/027 isolates, but was also found in other distantly related isolates (Curry et al., 2007) . There are conflicting data for several other non-027 strains carrying a similar deletion in the toxin regulatory gene. Thus, other factors are likely to play a role in the increased virulence of 027 strains.
In a previous study, we carried out whole-genome comparison of 75 C. difficile strains by microarray analysis (Fig. 1) . We found a distinctive lack of hybridization of the 39 end of tcdB in 027 strains (Fig. 2) compared with most other strains, including the sequenced strain 630 (Stabler et al., 2006) . Given the importance of toxin B to the pathogenesis of C. difficile, the aim of this study was to ascertain whether the hypervirulent 027 tcdB genes were distinct and whether there was sequence microheterogeneity within tcdB among the 027 strains.
METHODS
C. difficile was cultured using standard methods in an anaerobic cabinet. All C. difficile isolates were kindly supplied by Dale Gerding (Edward Hines Jr Veterans Affairs Hospital, Hines, IL, USA). Genomic DNA was prepared using a Wizard genomic DNA purification kit according to the manufacturer's guidelines. PCR amplifications were performed using standard methods with primers described in Supplementary Table S1 (available with the online journal). Sequencing reactions were set up using an ABI BigDye terminator cycle sequencing kit according to the manufacturer's guidelines, and processed using an ABI Prism 3730 DNA Analyzer. Chromas software version 2.31 was used to extract the sequence information, which was aligned using CLUSTAL_W.
RESULTS AND DISCUSSION
Whole-genome analysis of 75 C. difficile strains using a microarray has previously identified four distinct lineages Stabler et al., 2006) . One clade comprised 20 of the 21 ribotype 027 strains tested and was named the hypervirulent clade (Fig. 1) . Seventeen of the hypervirulent isolates represented seventeen subcategories of the BI restriction endonuclease analysis (REA) group (BI-1 to . Other studies have demonstrated that different BI REA patterns are more than 80 % related by dendrographic analysis . REA subtypes BI-1 to BI-5 were found in historic isolates obtained before 2001 , which are fluoroquinolone-sensitive. REA subtypes BI-6 to BI-17 were isolated after 2001; these are fluoroquinolone-resistant and are known as the epidemic hypervirulent isolates . Microarray analysis of the hypervirulent clade identified a distinct set of genes for these isolates that were classified as 'absent/ highly divergent' including a unique deletion/divergence pattern for the 39 end of tcdB (Fig. 2) (Stabler et al., 2006) . It has been shown that BI/NAP1/027 strains are toxinotype III with an A + B + toxinotype. The pathogenicity locus of toxinotype III strains is almost identical to VPI 10463, the toxinotype 0 reference strain, the only difference being the loss of a few restriction sites. BI-9 was an apparent ribotype 027 that clustered in HA1 clade (Fig. 1) , BI-1 to BI-3 were representative of historic fluoroquinolone-sensitive strains, BI-10 to BI-14 were representative of epidemic fluoroquinoloneresistant strains and BI-14 was a hypervirulent clade outlier (Fig. 1) . The loci are the same size in both toxinotypes, indicating that there are no deletions present in toxinotype III strains (Rupnik et al., 1998) . However, microarray probes did not bind to the 39 receptor-binding domain of tcdB (Fig. 3) , which was most likely due to sequence divergence of the 39 receptor-binding domain of tcdB, as the presence of this region was confirmed by PCR. Therefore, the sequence was sufficiently different from the C. difficile 630 sequence to prevent binding to the microarray reporters (Fig. 2) . The regions showing sequence divergence were e, f and g (Fig. 3) . These three regions were sequenced in this study from a selection of historic and epidemic BI subtypes including BI-9, which was of interest as it did not cluster in the hypervirulent clade ( Fig. 1) and did not possess the unique tcdB microarray hybridization pattern (Fig. 2) .
The sequence data for tcdB regions e, f and g identified deviations from the C. difficile 630 sequence (Table 1 , Supplementary Fig . S1a-c available with the online journal). All BI REA sequences tested except BI-9 showed sequence deviation from C. difficile 630 of greater than 5 % in all three regions (Table 1 ). This variation in sequence would be sufficiently different under the stringent microarray conditions to fail to hybridize to the reported elements on the microarray and therefore the sequence would appear to be absent/highly divergent. These data explain why the microarray data presented previously by Stabler et al. (2006) identified these regions of tcdB as absent/highly divergent. Sequence identity between REA type BI-1 and the other BI REA types tested, with the exception of BI-9, was 98-99 % for section e, 96-99 % for section f and 99-100 % for section g ( Table 2 ). The exception was BI-14 for region f, which had only 93 % identity to BI-1 (Table 2 ), but had a higher identity to 630 (95 %; Table 1 ). This was not unexpected, as BI-14 was a distinct outlier in the hypervirulent clade ( Fig. 1 ) and appears to be a mid-point between the two tcdB genotypes for this region. Sequence analysis of the three regions of tcdB for the REA BI-9 isolate demonstrated 100 % identity for regions e and f, and 99.7 % for region g to C. difficile 630. This is also consistent with the microarray data and the fact that BI-9 is not genotypically similar to the other BI isolates. The alteration in tcdB sequence resulted in a markedly altered TcdB protein sequence but did not include any translation terminators that would lead to a truncated protein (Fig. 4 , Supplementary Fig. S2a -c available with the online journal).
In conclusion, seven 027 strains were found to have a different 39-end tcdB sequence extending over 2.9 kb. By extrapolation of previous microarray data (Stabler et al., 2006) , it appears that this is a unique feature of the hypervirulent 027 strains with the exception of BI-9. It is possible that the divergent C-terminal binding domain may affect the binding capability of toxin B, potentially increasing the cell range to which the toxin binds. It is possible that the increased virulence observed in 027 strains may be due an altered binding avidity and/or alteration in host-cell specificity of toxin B, in addition to increased toxin production through deletions in tcdC.
